Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The use of Armored RNA as a multi-purpose internal control for RT-PCR.

Identifieur interne : 001B74 ( PubMed/Curation ); précédent : 001B73; suivant : 001B75

The use of Armored RNA as a multi-purpose internal control for RT-PCR.

Auteurs : Jeffery Stevenson [États-Unis] ; Weston Hymas ; David Hillyard

Source :

RBID : pubmed:18395804

Descripteurs français

English descriptors

Abstract

Real time reverse transcriptase-PCR (RT-PCR) is now used commonly for the detection of viral pathogens in respiratory samples. However, due to potential inhibition of the RT-PCR or inefficient extraction, this sample type can present significant challenges to accurate patient testing. The goal of this study was to create an internal control to be multiplexed in a real time RT-PCR assay for detecting a viral target in respiratory samples. This report describes an Armored RNA (aRNA) internal control developed originally to be multiplexed in a real time RT-PCR assay for detecting SARS-associated Coronavirus, but can be incorporated into any RT-PCR assay. The internal control primers and probe target a region in the coat protein gene of the E. coli F-specific bacteriophage ms2, which is contained within the aRNA.

DOI: 10.1016/j.jviromet.2008.02.007
PubMed: 18395804

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:18395804

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The use of Armored RNA as a multi-purpose internal control for RT-PCR.</title>
<author>
<name sortKey="Stevenson, Jeffery" sort="Stevenson, Jeffery" uniqKey="Stevenson J" first="Jeffery" last="Stevenson">Jeffery Stevenson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Associated Regional and University Pathologists, Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA. stevenj@aruplab.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Associated Regional and University Pathologists, Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hymas, Weston" sort="Hymas, Weston" uniqKey="Hymas W" first="Weston" last="Hymas">Weston Hymas</name>
</author>
<author>
<name sortKey="Hillyard, David" sort="Hillyard, David" uniqKey="Hillyard D" first="David" last="Hillyard">David Hillyard</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18395804</idno>
<idno type="pmid">18395804</idno>
<idno type="doi">10.1016/j.jviromet.2008.02.007</idno>
<idno type="wicri:Area/PubMed/Corpus">001B74</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B74</idno>
<idno type="wicri:Area/PubMed/Curation">001B74</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B74</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The use of Armored RNA as a multi-purpose internal control for RT-PCR.</title>
<author>
<name sortKey="Stevenson, Jeffery" sort="Stevenson, Jeffery" uniqKey="Stevenson J" first="Jeffery" last="Stevenson">Jeffery Stevenson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Associated Regional and University Pathologists, Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA. stevenj@aruplab.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Associated Regional and University Pathologists, Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hymas, Weston" sort="Hymas, Weston" uniqKey="Hymas W" first="Weston" last="Hymas">Weston Hymas</name>
</author>
<author>
<name sortKey="Hillyard, David" sort="Hillyard, David" uniqKey="Hillyard D" first="David" last="Hillyard">David Hillyard</name>
</author>
</analytic>
<series>
<title level="j">Journal of virological methods</title>
<idno type="ISSN">0166-0934</idno>
<imprint>
<date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>DNA Primers (genetics)</term>
<term>Humans</term>
<term>Levivirus (genetics)</term>
<term>RNA (chemistry)</term>
<term>Reference Standards</term>
<term>Respiratory Tract Infections (virology)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (methods)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction (standards)</term>
<term>Virus Diseases (diagnosis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN ()</term>
<term>Amorces ADN (génétique)</term>
<term>Humains</term>
<term>Infections de l'appareil respiratoire (virologie)</term>
<term>Levivirus (génétique)</term>
<term>Maladies virales (diagnostic)</term>
<term>Normes de référence</term>
<term>RT-PCR ()</term>
<term>RT-PCR (normes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>RNA</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>DNA Primers</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Maladies virales</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Levivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Amorces ADN</term>
<term>Levivirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr">
<term>RT-PCR</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en">
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections de l'appareil respiratoire</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Respiratory Tract Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Reference Standards</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>ARN</term>
<term>Humains</term>
<term>Normes de référence</term>
<term>RT-PCR</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Real time reverse transcriptase-PCR (RT-PCR) is now used commonly for the detection of viral pathogens in respiratory samples. However, due to potential inhibition of the RT-PCR or inefficient extraction, this sample type can present significant challenges to accurate patient testing. The goal of this study was to create an internal control to be multiplexed in a real time RT-PCR assay for detecting a viral target in respiratory samples. This report describes an Armored RNA (aRNA) internal control developed originally to be multiplexed in a real time RT-PCR assay for detecting SARS-associated Coronavirus, but can be incorporated into any RT-PCR assay. The internal control primers and probe target a region in the coat protein gene of the E. coli F-specific bacteriophage ms2, which is contained within the aRNA.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">18395804</PMID>
<DateCompleted>
<Year>2008</Year>
<Month>07</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">0166-0934</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>150</Volume>
<Issue>1-2</Issue>
<PubDate>
<Year>2008</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virological methods</Title>
<ISOAbbreviation>J. Virol. Methods</ISOAbbreviation>
</Journal>
<ArticleTitle>The use of Armored RNA as a multi-purpose internal control for RT-PCR.</ArticleTitle>
<Pagination>
<MedlinePgn>73-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviromet.2008.02.007</ELocationID>
<Abstract>
<AbstractText>Real time reverse transcriptase-PCR (RT-PCR) is now used commonly for the detection of viral pathogens in respiratory samples. However, due to potential inhibition of the RT-PCR or inefficient extraction, this sample type can present significant challenges to accurate patient testing. The goal of this study was to create an internal control to be multiplexed in a real time RT-PCR assay for detecting a viral target in respiratory samples. This report describes an Armored RNA (aRNA) internal control developed originally to be multiplexed in a real time RT-PCR assay for detecting SARS-associated Coronavirus, but can be incorporated into any RT-PCR assay. The internal control primers and probe target a region in the coat protein gene of the E. coli F-specific bacteriophage ms2, which is contained within the aRNA.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Stevenson</LastName>
<ForeName>Jeffery</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Associated Regional and University Pathologists, Institute for Clinical and Experimental Pathology, 500 Chipeta Way, Salt Lake City, UT 84108, USA. stevenj@aruplab.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hymas</LastName>
<ForeName>Weston</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hillyard</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2008</Year>
<Month>04</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>J Virol Methods</MedlineTA>
<NlmUniqueID>8005839</NlmUniqueID>
<ISSNLinking>0166-0934</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>63231-63-0</RegistryNumber>
<NameOfSubstance UI="D012313">RNA</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017909" MajorTopicYN="N">Levivirus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2007</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2008</Year>
<Month>02</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2008</Year>
<Month>02</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2008</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2008</Year>
<Month>7</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2008</Year>
<Month>4</Month>
<Day>9</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">18395804</ArticleId>
<ArticleId IdType="pii">S0166-0934(08)00068-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.jviromet.2008.02.007</ArticleId>
<ArticleId IdType="pmc">PMC7119664</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Clin Microbiol Rev. 2006 Jan;19(1):165-256</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16418529</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Sci (Lond). 2005 Oct;109(4):365-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16171460</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Infect Dis. 2006 May 25;6:87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16725022</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2005 Sep;43(9):4551-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16145106</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Virol. 2002 Dec;25 Suppl 3:S3-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12467772</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Chem. 2008 Feb;54(2):406-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18039718</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Genes Immun. 2005 Jun;6(4):279-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15815687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 Aug;42(8):3581-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15297501</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 Mar;42(3):987-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15004042</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 May;42(5):1863-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15131141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol Methods. 2007 Jun;142(1-2):10-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17222467</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biomol Tech. 2004 Sep;15(3):155-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15331581</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 Feb;42(2):841-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14766868</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2006 Aug;44(8):2714-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16891482</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Pathol. 1999 Apr;52(4):257-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10474515</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Microbiol. 2006 Feb;55(Pt 2):149-155</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16434706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 2004 Jul;42(7):3059-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15243060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B74 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001B74 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:18395804
   |texte=   The use of Armored RNA as a multi-purpose internal control for RT-PCR.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:18395804" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021